Morning Overview on MSN

Researchers think they’ve found a path to restoring human vision

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...
PharmiWeb

Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors

Seasoned biopharma industry leader brings more than 30 years of experience to support company’s growth trajectory —BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics, a clinical-stage biotechnology ...
TMCnet

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Pharmabiz

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Multiple Sclerosis News Today

Privosegtor granted FDA breakthrough status for optic neuritis

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Johns Hopkins-Led Team Creates First Map of Nerve Circuitry in Bone, Identifies Key Signals for Bone Repair

First discovered in the 1950s, NGF is now known to direct the growth, maintenance, proliferation and preservation of neurons ...